Conference Coverage

TAVR shows large survival benefit in diabetes patients


 

AT THE ESC CONGRESS 2013

The PARTNER trial was sponsored by Edwards Lifesciences, which markets the TAVR device used in the study. Dr. Lindman was an investigator in PARTNER and said that he had no disclosures.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

PCI in noninfarct coronaries helps STEMI patients
MDedge Cardiology
Prasugrel pretreatment ups bleeding risk in NSTE ACS
MDedge Cardiology
Risk of stopping dual-antiplatelet therapy after stenting depends upon the reason
MDedge Cardiology
Registry-based randomized clinical trials are here
MDedge Cardiology
On-site bypass rescue unnecessary for primary PCI
MDedge Cardiology
Prophylactic beta-blockers and noncardiac surgery: It's complicated!
MDedge Cardiology
High-volume, low-mortality hospitals have lowest postsurgical readmissions
MDedge Cardiology
ECG leads were misplaced in 3% of children in a single-center study
MDedge Cardiology
How to foil post-CABG aspirin resistance
MDedge Cardiology
FDA drops access points from Sapien transcatheter valve label
MDedge Cardiology